Literature DB >> 15917985

Acute renal failure due to mesangial proliferative glomerulonephritis in a pregnant woman with primary Sjögren's syndrome.

Fatma Ulku Adam1, Dilek Torun, Filiz Bolat, Aysegul Zumrutdal, Siren Sezer, Fatma Nurhan Ozdemir.   

Abstract

The most common form of renal involvement in Sjögren's syndrome (SS) is tubulointerstitial nephritis. Renal dysfunction is usually mild and subclinical. Glomerulonephritis (GMN) is rare in patients with SS. We report a 28-year-old multigravida patient with primary Sjögren's syndrome (pSS) and associated manifestations, who presented with acute renal failure in the 20th week of her fifth pregnancy. The complaints and clinical findings, positive Schirmer's test, findings of dry eye on ophthalmologic examination, and the salivary gland biopsy were compatible with SS. The patient exhibited no other clinical or laboratory findings indicative of other collagenous disease and/or rheumatoid arthritis. She refused renal biopsy, hesitating for fear of fetal loss; thus, based on the clinical and laboratory findings indicating rapidly progressive GMN and vasculitis, prednisolone, plasmapheresis, and one dose of cyclophosphamide were administered during the pregnancy. Hemodialysis five times weekly was performed. At the 28th week of gestation, she underwent a cesarean section due to early rupture of membranes and fetal distress. A healthy male boy was delivered. The renal biopsy performed 2 weeks after labor revealed mesangial proliferative glomerulonephritis. After the fourth cyclophosphamide treatment, her urinary output increased and she was discharged from the hemodialysis program. She remains in follow-up at our outpatient clinic free of hemodialysis for 4 months. This is the first report of mesangial proliferative GMN requiring dialysis in a pregnant pSS patient that has featured good maternal and fetal outcomes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917985     DOI: 10.1007/s10067-005-1131-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  13 in total

1.  Clinical and morphological features of kidney involvement in primary Sjögren's syndrome.

Authors:  N Bossini; S Savoldi; F Franceschini; S Mombelloni; M Baronio; I Cavazzana; B F Viola; B Valzorio; C Mazzucchelli; R Cattaneo; F Scolari; R Maiorca
Journal:  Nephrol Dial Transplant       Date:  2001-12       Impact factor: 5.992

Review 2.  Sjögren's syndrome.

Authors:  Habib Ur Rehman
Journal:  Yonsei Med J       Date:  2003-12-30       Impact factor: 2.759

3.  Renal tubular acidosis in primary Sjögren's syndrome.

Authors:  K C Siamopoulos; M Elisaf; A A Drosos; A A Mavridis; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

4.  Crescentic glomerulonephritis associated with membranous nephropathy in a case with primary Sjögren's syndrome.

Authors:  H Tatsumi; S Tateno; Y Hiki; H Shigematsu; Y Kobayashi
Journal:  Nephrol Dial Transplant       Date:  1998-10       Impact factor: 5.992

5.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

6.  The clinical picture of primary Sjögren's syndrome: a retrospective study.

Authors:  N A Pavlidis; J Karsh; H M Moutsopoulos
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

7.  The occurrence of renal involvement in primary Sjögren's syndrome: a study of 78 patients.

Authors:  M Pertovaara; M Korpela; T Kouri; A Pasternack
Journal:  Rheumatology (Oxford)       Date:  1999-11       Impact factor: 7.580

8.  Mesangial nephropathy in Sjögren's syndrome.

Authors:  S Gamrón; G Barberis; C M Onetti; I Strusberg; E Hliba; G Martellotto; H G Jara; A M Sesin
Journal:  Scand J Rheumatol       Date:  2000       Impact factor: 3.641

9.  Clinically significant and biopsy-documented renal involvement in primary Sjögren syndrome.

Authors:  A Goules; S Masouridi; A G Tzioufas; J P Ioannidis; F N Skopouli; H M Moutsopoulos
Journal:  Medicine (Baltimore)       Date:  2000-07       Impact factor: 1.889

Review 10.  Immunosuppressive drug use in pregnancy.

Authors:  Michelle Petri
Journal:  Autoimmunity       Date:  2003-02       Impact factor: 2.815

View more
  5 in total

Review 1.  Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2016-07-06

2.  Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Samih H Nasr; Nelson Leung; Julie Vrana; Carl Cramer; Carla M Nester; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-17       Impact factor: 8.237

3.  Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

Authors:  Sanjeev Sethi; Ladan Zand; Nelson Leung; Richard J H Smith; Dragan Jevremonic; Sandra S Herrmann; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

4.  Pregnancy outcomes in a patient with Sjögren's disease with renal involvement.

Authors:  Abhishek Joshi; Keelin O'Donoghue; Uzma Mahmood; Debasish Banerjee; Anita Banerjee
Journal:  Obstet Med       Date:  2013-07-22

5.  Renal involvement in primary Sjögren's syndrome: a clinicopathologic study.

Authors:  Saugar Maripuri; Joseph P Grande; Thomas G Osborn; Fernando C Fervenza; Eric L Matteson; James V Donadio; Marie C Hogan
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-13       Impact factor: 8.237

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.